Atorvastatin — $0 on Listed Strengths

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Chronic Kidney Disease

• Amlodipine
• Furosemide
• Lisinopril
• Losartan

Also listed for Coronary Artery Disease

• Aspirin
• Clopidogrel
• Metoprolol
• Nitroglycerin

Other medications in Heart & Cardiovascular

• Azilsartan
• Bempedoic Acid
• Benazepril
• Bisoprolol
• Bosentan
• Bumetanide
• Candesartan
• Cangrelor

About Atorvastatin

Atorvastatin is a cornerstone medication for managing high cholesterol, playing a vital role in preventing serious cardiovascular events like heart attacks and strokes. Understanding its benefits is crucial for your heart health journey. ### What is Atorvastatin and What Does It Treat? Atorvastatin is a widely prescribed medication belonging to a class of drugs known as statins. Its primary role is to lower high levels of "bad" cholesterol (LDL-cholesterol) and triglycerides in the blood, while simultaneously increasing levels of "good" cholesterol (HDL-cholesterol). High cholesterol is a significant risk factor for developing atherosclerosis, a condition where plaque builds up in your arteries, leading to heart disease, heart attacks, and strokes. By effectively managing cholesterol levels, atorvastatin helps reduce these risks, improving overall cardiovascular health for many patients. ### How Does Atorvastatin Work? As a statin, atorvastatin works by inhibiting an enzyme in the liver called HMG-CoA reductase. This enzyme is crucial for the production of cholesterol in the body. By blocking its action, atorvastatin reduces the amount of cholesterol the liver produces. This reduction prompts the liver to remove more LDL-cholesterol from the bloodstream, further lowering circulating levels. Over time, this mechanism helps to stabilize existing plaque in the arteries and can even reduce its size, making blood flow more freely and decreasing the likelihood of dangerous blockages. ### Understanding Typical Costs of Atorvastatin

The cost of atorvastatin can vary significantly depending on whether you're prescribed the brand-name drug (Lipitor) or its generic equivalent, your insurance coverage, and the pharmacy you use. Without insurance, a month's supply of generic atorvastatin can range from $15 to over $100, depending on the dosage and location. Even with insurance, many patients face co-pays, deductibles, and coverage gaps that can make essential medications like atorvastatin a financial burden. These costs can deter individuals from consistently taking their medication, putting their heart health at risk. ### How TheDrugClub Saves You Money on Atorvastatin

At TheDrugClub, we believe that managing your heart health shouldn't break the bank. We understand the financial challenges many Americans face when trying to afford their prescriptions. Our membership program is designed to simplify access to critical medications. Instead of navigating confusing insurance plans or worrying about high out-of-pocket costs, TheDrugClub members can receive their generic ator

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Atorvastatin is approved for (FDA label)

Atorvastatin Calcium Tablets are indicated: To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia. Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH).

Source: Read the full FDA label on DailyMed. Label effective date: September 8, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Atorvastatin (FDA label)

Atorvastatin calcium tablets, USP: 10 mg of atorvastatin calcium tablets, USP: white to off-white, oval, biconvex film-coated tablets, engraved “APO” on one side, “A10” on the other side. 20 mg of atorvastatin calcium tablets, USP: white to off-white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV20” on the other side. 40 mg of atorvastatin calcium tablets, USP: white to off-white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV40” on the other side. 80 mg of atorvastatin calcium tablets, USP: white to off-white, oval, biconvex film-coated tablets, engraved “APO” on one side, “ATV80” on the other side. Tablets: 10 mg; 20 mg; 40 mg 80 mg of atorvastatin ( 3 ).

Source: FDA prescribing information (DailyMed). Set ID: d9adb9e4-c495-9530-e5e3-7e3b01d53e4c. SPL document ID: 68d09be6-1a04-4117-85dc-1d975e475c6a. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Atorvastatin (FDA label)

The following important adverse reactions are described below and elsewhere in the labeling: Myopathy and Rhabdomyolysis [see Warnings and Precautions ( 5.1 )] Immune-Mediated Necrotizing Myopathy [see Warnings and Precautions ( 5.2 )] Hepatic Dysfunction [see Warnings and Precautions ( 5.3 )] Increases in HbA1c and Fasting Serum Glucose Levels [see Warnings and Precautions ( 5.4 )] Most common adverse reactions (incidence ≥ 5%) are nasopharyngitis, arthralgia, diarrhea, pain in extremity, and urinary tract infection ( 6.1 ).

Source: FDA prescribing information (DailyMed). Set ID: d9adb9e4-c495-9530-e5e3-7e3b01d53e4c. SPL document ID: 68d09be6-1a04-4117-85dc-1d975e475c6a. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Atorvastatin (FDA label)

Acute liver failure or decompensated cirrhosis [see Warnings and Precautions ( 5.3 )] Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium tablets. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported [see Adverse Reactions ( 6.2 )] . Acute liver failure or decompensated cirrhosis ( 4 ). Hypersensitivity to atorvastatin or any excipient in atorvastatin calcium tablets ( 4 ).

Source: FDA prescribing information (DailyMed). Set ID: d9adb9e4-c495-9530-e5e3-7e3b01d53e4c. SPL document ID: 68d09be6-1a04-4117-85dc-1d975e475c6a. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Atorvastatin (FDA label)

Myopathy and Rhabdomyolysis: Risk factors include age 65 years or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher atorvastatin calcium dosage. Discontinue atorvastatin calcium tablets if markedly elevated CK levels occur or myopathy is diagnosed or suspected. Temporarily discontinue atorvastatin calcium in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis. Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing atorvastatin calcium dosage. Instruct patients to promptly report unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever ( 2.5 , 5.1 , 7.1 , 8.5 , 8.6 ). Immune-Mediated Necrotizing Myopathy (IMNM): Rare reports of IMNM, an autoimmune myopathy, have been reported with statin use. Discontinue atorvastatin calcium tablets if IMNM is suspected ( 5.2 ). Hepatic Dysfunction: Increases in serum transaminases have occurred, some persistent.

Source: FDA prescribing information (DailyMed). Set ID: d9adb9e4-c495-9530-e5e3-7e3b01d53e4c. SPL document ID: 68d09be6-1a04-4117-85dc-1d975e475c6a. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Atorvastatin (FDA label)

See full prescribing information for details regarding concomitant use of atorvastatin calcium with other drugs or grapefruit juice that increase the risk of myopathy and rhabdomyolysis ( 2.5 , 7.1 ). Rifampin: May reduce atorvastatin plasma concentrations. Administer simultaneously with atorvastatin ( 7.2 ). Oral Contraceptives: May increase plasma levels of norethindrone and ethinyl estradiol; consider this effect when selecting an oral contraceptive ( 7.3 ). Digoxin: May increase digoxin plasma levels; monitor patients appropriately ( 7.3 ). 7.1 Drug Interactions that may Increase the Risk of Myopathy and Rhabdomyolysis with Atorvastatin Calcium Atorvastatin calcium is a substrate of CYP3A4 and transporters (e.g., OATP1B1/1B3, P-gp, or BCRP). Atorvastatin calcium plasma levels can be significantly increased with concomitant administration of inhibitors of CYP3A4 and transporters.

Source: FDA prescribing information (DailyMed). Set ID: d9adb9e4-c495-9530-e5e3-7e3b01d53e4c. SPL document ID: 68d09be6-1a04-4117-85dc-1d975e475c6a. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.